Authors:
Lurain, NS
Weinberg, A
Crumpacker, CS
Chou, SW
Citation: Ns. Lurain et al., Sequencing of cytomegalovirus UL97 gene for genotypic antiviral resistancetesting, ANTIM AG CH, 45(10), 2001, pp. 2775-2780
Citation: Jl. Zhang et Cs. Crumpacker, Human immunodeficiency virus type 1 RNA in peripheral blood mononuclear cells of patients receiving prolonged highly active antiretroviral therapy, J INFEC DIS, 184(10), 2001, pp. 1341-1344
Authors:
Masur, H
Kaplan, JE
Holmes, KK
Alston, BL
Ampel, N
Anderson, JR
Baker, AC
Barr, D
Bartlett, JG
Bennett, JE
Benson, CA
Bozzette, SA
Chaisson, RE
Crumpacker, CS
Currier, JS
Deyton, L
Drew, WL
Duncan, WR
Eisinger, RW
El-Sadr, W
Feinberg, J
Freedberg, KA
Furrer, H
Gnann, JW
Goldberger, MJ
Goldie, S
Goosby, EP
Gross, PA
Hafner, R
Havlir, D
Hooton, TM
Jabs, DA
Jacobson, MA
Janoff, E
Kitahata, M
Kovacs, JV
Leport, C
Levin, MJ
Lopez, JC
Marco, M
Mayers, DL
Melnick, DA
Mofenson, LM
Montaner, JSG
Moore, R
Neaton, J
Nelson, C
O'Neill, JF
Palefsky, J
Pau, A
Phair, JP
Piscitelli, S
Polis, MA
Quinn, TC
Reiss, P
Rimland, D
Sears, CL
Seeff, L
Sepkowitz, KA
Slama, TG
Sloand, EM
Spector, SA
Thomas, DL
Van Dyke, RB
Watts, DH
Wheat, LJ
Whitcup, SM
Williams, P
Wright, TC
Castro, KG
DeCock, KM
Dowell, SF
Dworkin, MS
Dykewicz, C
Ellerbrock, T
Hajjeh, R
Holmberg, S
Holtgrave, DR
Jaffe, HW
Jones, JL
Juranek, DD
Mast, E
Navin, T
Pellett, PE
Reeves, WC
Stewart, JA
Villarino, ME
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, CLIN INF D, 30, 2000, pp. S29-S65
Citation: Jl. Zhang et al., Enhancement of the basal-level activity of HIV-1 long terminal repeat by HIV-1 nucleocapsid protein, VIROLOGY, 268(2), 2000, pp. 251-263
Authors:
Dezube, BJ
Dahl, TA
Wong, TK
Chapman, B
Ono, M
Yamaguchi, N
Gillies, SD
Chen, LB
Crumpacker, CS
Citation: Bj. Dezube et al., A fusion inhibitor (FP-21399) for the treatment of human immunodeficiency virus infection: A phase I study, J INFEC DIS, 182(2), 2000, pp. 607-610
Citation: Sw. Chou et al., Interstrain variation in the human cytomegalovirus DNA polymerase sequenceand its effect on genotypic diagnosis of antiviral drug resistance, ANTIM AG CH, 43(6), 1999, pp. 1500-1502
Citation: Pl. Sharma et Cs. Crumpacker, Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: a comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val, J VIROLOGY, 73(10), 1999, pp. 8448-8456
Authors:
Masur, H
Kaplan, JE
Holmes, KK
Alston, BL
Ampel, N
Anderson, JR
Baker, AC
Barr, D
Bartlett, JG
Bennett, JE
Benson, CA
Bozzette, SA
Chaisson, RE
Crumpacker, CS
Currier, JS
Deyton, L
Drew, WL
Duncan, WR
Eisinger, RW
El-Sadr, W
Feinberg, J
Freedberg, KA
Furrer, H
Gnann, JW
Goldberger, MJ
Goldie, S
Goosby, EP
Gross, PA
Hafner, R
Havlir, D
Hooton, TM
Jabs, DA
Jacobson, MA
Janoff, E
Kitahata, M
Kovacs, JV
Leport, C
Levin, MJ
Lopez, JC
Marco, M
Mayers, DL
Melnick, DA
Mofenson, LM
Montaner, JSG
Moore, R
Neaton, J
Nelson, C
O'Neill, JF
Palefsky, J
Pau, A
Phair, JP
Piscitelli, S
Polis, MA
Quinn, TC
Reiss, P
Rimland, D
Sears, CL
Seeff, L
Sepkowitz, KA
Slama, TG
Sloand, EM
Spector, SA
Thomas, DL
Van Dyke, RB
Watts, DH
Wheat, LJ
Whitcup, SM
Williams, P
Wright, TC
Castro, KG
DeCock, KM
Dowell, SF
Dworkin, MS
Dykewicz, C
Ellerbrock, T
Hajjeh, R
Holmberg, S
Holtgrave, DR
Jaffe, HW
Jones, JL
Juranek, DD
Mast, E
Navin, T
Pellett, PE
Reeves, WC
Stewart, JA
Villarino, ME
Kaplan, JE
Citation: H. Masur et al., 1999 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus, ANN INT MED, 131(11), 1999, pp. 873-908